Trials / Conditions / ph+ Acute Lymphoblastic Leukemia
ph+ Acute Lymphoblastic Leukemia
3 registered clinical trials studyying ph+ Acute Lymphoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin ( NCT04747912 | University of Chicago | Phase 2 |
| Unknown | Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patient NCT02690922 | Tongji Hospital | Phase 4 |
| Completed | Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL) NCT01207440 | Ariad Pharmaceuticals | Phase 2 |